Company / SG&A Expense
Definitive Healthcare Corp. SG&A Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$58.9M
FY2025
5-year range
$4.0M / $58.9M
FY2021-FY2025
Trend
+14.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 4 consecutive years, from $4M in FY2021 to $59M in FY2025.
Based on SEC 10-K filings.
$59M in FY2025 with a 3-year CAGR of +65.7%.
Increased from $33M to $59M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +65.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Definitive Healthcare Corp.'s sg&a expense has grown for 4 consecutive years.
- 3-year CAGR of +65.7%, indicating consistent growth.
- In FY2025, sg&a expense increased 14.2% year-over-year.
- Lowest sg&a expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $58.9M | +14.2% |
| FY2024 | $51.6M | +56.9% |
| FY2023 | $32.9M | +154.2% |
| FY2022 | $12.9M | +224.9% |
| FY2021 | $4.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026